Home › Myoclonic Epilepsies › North Carolina
Myoclonic Epilepsies clinical trials in North Carolina
3 studies for Myoclonic Epilepsies are looking for participants at sites in North Carolina.
Cities in North Carolina
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Duke Children's Hospital & Health Center, Durham
RecruitingPhase 1/2
6 Months – 17 Years · All sexes · Updated Sep 22, 2026 · NCT05419492A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Duke University Health System, Durham
- Science 37, Morrisville
- Wake Forest Baptist Medical Center, Winston-Salem
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Duke University Health Systems, Durham
RecruitingPhase 1/2
Ages 2 to 12 · All sexes · Updated Sep 3, 2026 · NCT07531745From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.